Clinical use of AMD3100 to mobilize CD34+ cells in patients affected by non-Hodgkin's lymphoma or multiple myeloma

J Clin Oncol. 2005 Jun 1;23(16):3871-2; author reply 3872-3. doi: 10.1200/JCO.2005.55.250.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antigens, CD34 / blood
  • Antigens, CD34 / drug effects
  • Benzylamines
  • Cyclams
  • Hematopoietic Stem Cell Mobilization / methods*
  • Heterocyclic Compounds / therapeutic use*
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / immunology
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / immunology
  • Receptors, CXCR4 / antagonists & inhibitors*

Substances

  • Antigens, CD34
  • Benzylamines
  • Cyclams
  • Heterocyclic Compounds
  • Receptors, CXCR4
  • plerixafor